Vertex Pharmaceuticals (VRTX34.SA) Q3 2017 Earnings

26JulConfirmed
Q4 2016
Q1 2017
Q2 2017
Q3 2017
0.5
0.77
1.04
1.3

Details

Expected EPS
1.129554
Actual EPS
1.2236835
Surprise EPS
0.09
Surprise Percent
+8.33%

Description

Vertex Pharmaceuticals (VRTX34.SA) has reported earnings of 1.2236835 per share for Q3 2017.

0 Comments

Share your thoughts